PlainRecalls
FDA Drug Moderate Class II Ongoing

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.

Reported: March 26, 2025 Initiated: March 7, 2025 #D-0290-2025

Product Description

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.

Reason for Recall

Super-Potent Drug: Out of specification potency results were obtained.

Details

Recalling Firm
Mylan Institutional, Inc.
Units Affected
347 Cartons
Distribution
Nationwide in the USA
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.. Recalled by Mylan Institutional, Inc.. Units affected: 347 Cartons.
Why was this product recalled?
Super-Potent Drug: Out of specification potency results were obtained.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 26, 2025. Severity: Moderate. Recall number: D-0290-2025.